{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:03:01Z","timestamp":1790672581485,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6981,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1097\/01.lab.0000106503.65258.2b","type":"journal-article","created":{"date-parts":[[2003,12,23]],"date-time":"2003-12-23T02:57:46Z","timestamp":1072148266000},"page":"1849-1858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Activated Proliferation of B-Cell Lymphomas\/Leukemias with the SHP1 Gene Silencing by Aberrant CpG Methylation"],"prefix":"10.1016","volume":"83","author":[{"given":"Maho","family":"Koyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Ouchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuo","family":"Nishiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaatsu","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Seino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib1","first-page":"95","article-title":"Inhibition of DNA methylation by 5-aza-2\u2032-deoxycytidine suppresses the growth of human tumor cell lines","volume":"58","author":"Bender","year":"1998","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1471-4914(02)02314-6","article-title":"Epigenomics and epigenetic therapy of cancer","volume":"8","author":"Brown","year":"2002","journal-title":"Trends Mol Med"},{"issue":"9","key":"10.1097\/01.LAB.0000106503.65258.2B_bib3","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/sj.leu.2402214","article-title":"Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation","volume":"15","author":"Bruecher-Encke","year":"2001","journal-title":"Leukemia"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/intimm\/11.12.1999","article-title":"The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds","volume":"11","author":"Carter","year":"1999","journal-title":"Int Immunol"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib5","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1471-4914(02)02303-1","article-title":"Histone modification: The \u2018next wave' in cancer therapeutics","volume":"8","author":"Chung","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/1074-7613(95)90075-6","article-title":"Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection","volume":"2","author":"Cyster","year":"1995","journal-title":"Immunity"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1097-0142(19890915)64:6<1248::AID-CNCR2820640614>3.0.CO;2-5","article-title":"The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma","volume":"64","author":"Daibata","year":"1989","journal-title":"Cancer"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.186.9.1575","article-title":"Downregurated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes","volume":"186","author":"Delibrias","year":"1997","journal-title":"J Exp Med"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib9","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"61","author":"Esteller","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib10","first-page":"793","article-title":"Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia","volume":"59","author":"Esteller","year":"1999","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1024","article-title":"Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumors","volume":"196","author":"Esteller","year":"2002","journal-title":"J Pathol"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib12","first-page":"67","article-title":"Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients","volume":"59","author":"Esteller","year":"1999","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib14","first-page":"1090","article-title":"Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability","volume":"59","author":"Fleisher","year":"1999","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib15","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1038\/sj.onc.1204750","article-title":"Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer","volume":"20","author":"Fulda","year":"2001","journal-title":"Oncogene"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00286709","article-title":"Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma","volume":"83","author":"Greger","year":"1989","journal-title":"Hum Genet"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib17","first-page":"722","article-title":"Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B","volume":"56","author":"Herman","year":"1996","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib18","first-page":"4525","article-title":"Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers","volume":"55","author":"Herman","year":"1995","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib19","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","article-title":"Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma","volume":"95","author":"Herman","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib20","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1073\/pnas.94.9.4681","article-title":"Mutagenicity of 5-aza-2\u2032-deoxycytidine is mediated by the mammalian DNA methyltransferase","volume":"94","author":"Jackson-Grusby","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib21","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib22","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1182\/blood.V93.12.4347","article-title":"Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies","volume":"93","author":"Katzenellenbogen","year":"1999","journal-title":"Blood"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.184.3.1111","article-title":"Genetic analysis reveals cell type- specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1","volume":"184","author":"Lorenz","year":"1996","journal-title":"J Exp Med"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nm0795-686","article-title":"5\u2032 CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16\/CDKN2\/MTS1 in human cancers","volume":"1","author":"Merlo","year":"1995","journal-title":"Nat Med"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib25","first-page":"155","article-title":"A novel T-cell line derived from adult T-cell leukemia","volume":"71","author":"Miyoshi","year":"1980","journal-title":"Gann"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-4608(96)00395-0","article-title":"Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma","volume":"98","author":"Ohtani-Fujita","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib27","first-page":"6390","article-title":"Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias\/lymphomas","volume":"62","author":"Oka","year":"2002","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)62535-7","article-title":"Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas\/leukemias: Combination analysis with cDNA expression array and tissue microarray","volume":"159","author":"Oka","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.184.3.839","article-title":"Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase","volume":"184","author":"Pani","year":"1996","journal-title":"J Exp Med"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib30","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1084\/jem.181.6.2077","article-title":"Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling","volume":"181","author":"Pani","year":"1995","journal-title":"J Exp Med"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib31","first-page":"51","article-title":"5-Aza-2\u2032-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: Past, present and future trends","volume":"7","author":"Pinto","year":"1993","journal-title":"Leukemia"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib32","first-page":"765","article-title":"Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors","volume":"60","author":"Prowse","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/mr.55.3.451-458.1991","article-title":"DNA methylation and gene expression","volume":"55","author":"Razin","year":"1991","journal-title":"Microbiol Rev"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib34","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1128\/MCB.18.11.6457","article-title":"The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53","volume":"18","author":"Robertson","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib35","first-page":"880","article-title":"Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene","volume":"48","author":"Sakai","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood.V92.4.1374.416a33_1374_1383","article-title":"Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma\/leukemia associated with Epstein-Barr virus infection","volume":"92","author":"Tsuchiyama","year":"1998","journal-title":"Blood"},{"key":"10.1097\/01.LAB.0000106503.65258.2B_bib37","first-page":"S24","article-title":"A randomized phase II study on the effects of 5-Aza-2\u2032-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: An EORTC Leukemia Cooperative Group phase II study (06893)","volume":"11","author":"Willemze","year":"1997","journal-title":"Leukemia"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722034389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722034389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T13:19:59Z","timestamp":1675948799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722034389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0023683722034389"],"URL":"https:\/\/doi.org\/10.1097\/01.lab.0000106503.65258.2b","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activated Proliferation of B-Cell Lymphomas\/Leukemias with the SHP1 Gene Silencing by Aberrant CpG Methylation","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/01.LAB.0000106503.65258.2B","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}